Ebola Vaccine Enters Final Trial Phase

An Ebola vaccine candidate enters the final phase of its trial Saturday (3/7) in Guinea. If successful, a vaccine could be ready for use in five or six months. The VSV-EBOV vaccine was developed by Canada’s Public Health Agency. World Health Organization vaccine expert Dr. Marie-Pierre Préziosi said Phase III will be conducted in the Basse Guinée region. It’s had the highest number of Ebola cases in the country “Phase III trial aims to test for safety and efficacy or...

© La Voix de l'Amérique - jeudi 5 mars 2015